Eulav Asset Management Edwards Lifesciences Corp Transaction History

Eulav Asset Management

$4.11 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$106.37 - $130.68 $12 Million - $14.8 Million	-113,010 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $11.6 Million - $13.9 Million	113,010 New	113,010 $12.8 Million
Q2 2021 Aug 06, 2021	SELL	$83.84 - $104.76 $10.3 Million - $12.9 Million	-123,000 Closed	0 $0
Q1 2021 Apr 30, 2021	SELL	$78.68 - $90.67 $550,760 - $634,690	-7,000 Reduced 5.38%	123,000 $10.3 Million
Q4 2020 Feb 16, 2021	SELL	$71.69 - $91.23 $430,140 - $547,380	-6,000 Reduced 4.41%	130,000 $11.9 Million
Q3 2020 Nov 05, 2020	BUY	$67.19 - $87.44 $9.14 Million - $11.9 Million	136,000 New	136,000 $10.9 Million
Q2 2020 Aug 11, 2020	SELL	$57.54 - $76.95 $2.19 Million - $2.92 Million	-38,000 Closed	0 $0
Q1 2020 Apr 27, 2020	SELL	$52.41 - $81.0 $366,870 - $567,000	-7,000 Reduced 15.56%	38,000 $7.17 Million
Q4 2019 Feb 13, 2020	SELL	$71.7 - $82.09 $215,100 - $246,270	-3,000 Reduced 6.25%	45,000 $10.5 Million
Q3 2019 Nov 12, 2019	SELL	$61.55 - $75.43 $307,750 - $377,150	-5,000 Reduced 9.43%	48,000 $10.6 Million
Q2 2019 Aug 05, 2019	SELL	$55.74 - $64.41 $111,480 - $128,820	-2,000 Reduced 3.64%	53,000 $9.79 Million
Q1 2019 May 13, 2019	SELL	$47.89 - $64.05 $47,890 - $64,050	-1,000 Reduced 1.79%	55,000 $10.5 Million
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $788,970 - $967,980	-17,000 Reduced 23.29%	56,000 $8.58 Million
Q3 2018 Oct 26, 2018	SELL	$45.7 - $58.03 $274,200 - $348,180	-6,000 Reduced 7.59%	73,000 $12.7 Million
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $382,050 - $461,700	-9,000 Reduced 10.23%	79,000 $11.5 Million
Q1 2018 May 09, 2018	SELL	$37.19 - $47.45 $483,469 - $616,850	-13,000 Reduced 12.87%	88,000 $12.3 Million
Q4 2017 Feb 14, 2018	SELL	$33.79 - $39.39 $439,270 - $512,070	-13,000 Reduced 11.4%	101,000 $11.4 Million
Q3 2017 Nov 14, 2017	SELL	$36.29 - $38.83 $217,740 - $232,980	-6,000 Reduced 5.0%	114,000 $12.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	120,000	120,000 $14.2 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

Vanguard Group Inc Valley Forge, PA

62.6M
Shares

$4.68 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.81 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

31.5M
Shares

$2.36 Billion
0.37% of portfolio
State Street Corp Boston, MA

26.3M
Shares

$1.96 Billion
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

13.5M
Shares

$1.01 Billion
0.07% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eulav Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Eulav Asset Management with notifications on news.

Account